In formal terms, the DEA announced that it is adjusting the 2024 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). As Beth Mole explained at Ars Technica, the DEA is able to regulate this medication due to its classification as a Schedule II drug
The mechanism involves changes in sex hormone binding globulin from rapid weight loss, reduced peripheral estrogen production from fat tissue reduction, and hypothalamic-pituitary-ovarian axis response to caloric restriction
Your body can only absorb calcium, the primary component of bone, when vitamin D is present

By donating acetyl groups to NF-B p65/RelA, ALC enhances transcription of the GRM2 gene encoding metabotropic glutamate 2 (mGlu2) receptors.[11][12] This upregulation of mGlu2 receptors at nerve terminals produces analgesia and prevents spinal sensitization, with effects that persist for weeks to months after discontinuationa feature distinguishing ALC from conventional analgesics.[11] In experimental models, ALC blocks wind-up and long-term potentiation in dorsal horn neurons, key processes underlying central sensitization.[11] The analgesic effects of ALC outlast the end of treatment in mouse models of chronic inflammatory and neuropathic pain, with effects persisting 37 days after drug withdrawal compared to 7-15 days for pregabalin or amitriptyline.[11] Clinical evidence in fibromyalgia (a prototypical central sensitization condition) supports this mechanism, with multiple RCTs demonstrating benefit.[11] Combination Strategies for Central Sensitization: ALC 1,500-2,000 mg/day + PEA 1,200 mg/day (demonstrated synergy in fibromyalgia)[3] + Magnesium 400-600 mg/day (complementary glutamate modulation) + Low-dose naltrexone (complementary anti-sensitization mechanisms) 2
